A detailed history of Lake Point Wealth Management transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Lake Point Wealth Management holds 400 shares of BMRN stock, worth $26,652. This represents 0.02% of its overall portfolio holdings.

Number of Shares
400
Previous 400 -0.0%
Holding current value
$26,652
Previous $31,000 6.45%
% of portfolio
0.02%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 21, 2019

BUY
$80.14 - $106.07 $32,056 - $42,428
400 New
400 $34,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Lake Point Wealth Management Portfolio

Follow Lake Point Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lake Point Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Lake Point Wealth Management with notifications on news.